AMPICILLIN AND SULBACTAM Drug Patent Profile
✉ Email this page to a colleague
When do Ampicillin And Sulbactam patents expire, and when can generic versions of Ampicillin And Sulbactam launch?
Ampicillin And Sulbactam is a drug marketed by Acs Dobfar, Antibiotice, Astral, Eugia Pharma Speclts, Hikma, Hospira Inc, Hq Speclt Pharma, Istituto Bio Ita Spa, Pharm Assoc, Sandoz, and Steriscience. and is included in twenty-three NDAs.
The generic ingredient in AMPICILLIN AND SULBACTAM is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMPICILLIN AND SULBACTAM?
- What are the global sales for AMPICILLIN AND SULBACTAM?
- What is Average Wholesale Price for AMPICILLIN AND SULBACTAM?
Summary for AMPICILLIN AND SULBACTAM
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 23 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 17 |
Patent Applications: | 206 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMPICILLIN AND SULBACTAM at DailyMed |
![AMPICILLIN AND SULBACTAM drug patent expirations Drug patent expirations by year for AMPICILLIN AND SULBACTAM](/p/graph/s/t/AMPICILLIN_AND_SULBACTAM-patent-expirations.png)
Recent Clinical Trials for AMPICILLIN AND SULBACTAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Konya Training and Research Hospital | Phase 4 |
Konya Meram State Hospital | Phase 4 |
Assiut University | Phase 4 |
Pharmacology for AMPICILLIN AND SULBACTAM
Drug Class | Penicillin-class Antibacterial beta Lactamase Inhibitor |
Mechanism of Action | beta Lactamase Inhibitors |